MARLBOROUGH – Six months after GE Healthcare Life Sciences announced it will move its U.S. headquarters from New Jersey to Marlborough, the biotech giant is on track to launch its operations in the city this summer.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.